TP53 and hepatocellular carcinoma: In principle, the 309T > G polymorphism (SNP 309, rs2279744), located in the intronic p53-responsive promoter of MDM2, has the effect of increasing Mdm2 protein levels and is associated with the early onset of HCC in patients with chronic HCV infection [62,136].